Associated Papers
A Cohort Study of CNS Tumors in Multiple Endocrine Neoplasia Type 1.
Graillon T et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2024
38630553 (PubMed )
Supplement: ccr-23-3308_supplementary_table_s2_suppts2.xlsx › Feuil1
Super-enhancer hijacking drives ectopic expression of hedgehog pathway ligands in meningiomas.
Youngblood MW et al.
Nature Communications, 2023
37805627 (PubMed )
Supplement: 41467_2023_41926_MOESM3_ESM.xlsx › SD1
NF2 Alteration/22q Loss Is Associated with Recurrence in WHO Grade 1 Sphenoid Wing Meningiomas.
Sakai Y et al.
Cancers, 2022
35804955 (PubMed )
Supplement: cancers-14-03183-s001.zip › supplementary_table_S4.xlsx › supplementary_table
Prognostic impact of genetic alterations and methylation classes in meningioma.
Berghoff AS et al.
Brain Pathology (zurich, Switzerland), 2022
35213082 (PubMed )
Supplement: BPA-32-e12970-s001.xlsx › Sheet1
Loss-of-Function Mutations in TRAF7 and KLF4 Cooperatively Activate RAS-Like GTPase Signaling and Promote Meningioma Development.
Najm P et al.
Cancer Research, 2021
Whole-Exome Sequencing Reveals Recurrent but Heterogeneous Mutational Profiles in Sporadic WHO Grade 1 Meningiomas.
González-Tablas M et al.
Frontiers in Oncology, 2021
34868937 (PubMed )
Supplement: DataSheet_1.docx
Phenotypic spectrum and transcriptomic profile associated with germline variants in TRAF7.
Castilla-Vallmanya L et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2020
Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations.
Reuss DE et al.
Acta Neuropathologica, 2013
Select a paper to view details